Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ruchong Chen and Shiyue Li.
Connection Strength

3.881
  1. Response. Chest. 2020 12; 158(6):2700-2701.
    View in: PubMed
    Score: 0.916
  2. Impaired pulmonary function in discharged patients with COVID-19: more work ahead. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.894
  3. The use of non-invasive ventilation in COVID-19: A systematic review. Int J Infect Dis. 2021 May; 106:254-261.
    View in: PubMed
    Score: 0.234
  4. Clinical Features of Coronavirus Disease 2019 Patients With Mechanical Ventilation: A Nationwide Study in China. Crit Care Med. 2020 09; 48(9):e809-e812.
    View in: PubMed
    Score: 0.225
  5. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun; 55(6).
    View in: PubMed
    Score: 0.222
  6. Serum amyloid A is a predictor for prognosis of COVID-19. Respirology. 2020 07; 25(7):764-765.
    View in: PubMed
    Score: 0.220
  7. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
    View in: PubMed
    Score: 0.220
  8. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
    View in: PubMed
    Score: 0.219
  9. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 05; 7(5):e362-e363.
    View in: PubMed
    Score: 0.219
  10. Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management Guidelines. Open Forum Infect Dis. 2021 Aug; 8(8):ofab376.
    View in: PubMed
    Score: 0.060
  11. Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
    View in: PubMed
    Score: 0.059
  12. Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
    View in: PubMed
    Score: 0.059
  13. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J. 2021 01; 57(1).
    View in: PubMed
    Score: 0.058
  14. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
    View in: PubMed
    Score: 0.055
  15. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
    View in: PubMed
    Score: 0.055
  16. Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. J Thorac Dis. 2020 May; 12(5):1811-1823.
    View in: PubMed
    Score: 0.055
  17. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 04 30; 382(18):1708-1720.
    View in: PubMed
    Score: 0.054
  18. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 03; 21(3):335-337.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.